Related Experiment Videos
Metachromatic leukodystrophy caused by a partial cerebroside sulfatase
Clinical Genetics
|April 1, 1982
Summary
This study identifies a partial cerebroside sulfatase defect in an atypical form of metachromatic leukodystrophy. The patient exhibits profound arylsulfatase A deficiency, impacting sulfatide hydrolysis.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Metachromatic leukodystrophy (MLD) is a lysosomal storage disorder caused by arylsulfatase A (ARSA) deficiency.
- Patients typically present with progressive neurological decline due to sulfatide accumulation.
- This case presents an atypical form of MLD with a unique enzymatic profile.
Observation:
- A patient with long-standing neuropathy and myopathy showed profound ARSA deficiency in leukocytes and urine.
- Fibroblast cultures revealed reduced ARSA activity (10-20% of normal) with altered substrate hydrolysis.
- Urine analysis detected metachromatic material co-chromatographing with cerebroside sulfate.
Findings:
- The patient's ARSA enzyme exhibited normal properties but lacked cerebroside sulfatase activity.
- Sulfatide hydrolysis in cultured fibroblasts was attenuated.
- A partial defect in cerebroside sulfatase activity was identified, characterized by substrate hydrolysis dependent on bile salt concentration (Type II activation).
Implications:
- This finding suggests a distinct subtype of metachromatic leukodystrophy with a partial ARSA defect.
- Understanding this atypical presentation may refine diagnostic approaches for MLD.
- Further research into the specific molecular mechanisms underlying this partial defect is warranted.